SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc.
PVCT 0.06400.0%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Khris Smith who wrote (12720)3/14/2014 1:34:58 PM
From: boomertree2   of 13111
 
I have no interest in the lawsuit other than as a shareholder like you. The officers are paying the money back to the company, so the cash settlement and option forfeiture benefits all shareholders. I only learned of the settlement terms from the 10-k published yesterday. The settlement likely would not have been reached with the stated terms unless management believed their was serious risk of a finding of breach of fiduciary duty or worse if the matter was litigated to a decision. The alleged excessive compensation ($15 million cash plus stock options) raises serious questions of trust, integrity and ethics. I believe their resignation at the June Board meeting with a competent slate of new officers identified to take their place would be viewed very positively by the market. The existing officers have no experience in bringing a new drug completely through the FDA trial process or commercializing a new drug through a sale or partnership with a pharma company. A new slate of officers with that substantive experience would be more qualified to maximize shareholder value. I would view the exodus of unqualified officers with a tainted ethics and integrity history, in exchange for qualified experienced trustworthy officers as a very positive move. The stock value is moving up, but how much more valuable would our shares be if the company had avoided the dilutive offerings and used the $15 million for legitimate company purposes.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext